Study of Compound Danshen Dripping Pills to Treat Acute Mountain Sickness

Learn more about:
Related Clinical Trial
Effect of Acetazolamide on Sleep Disordered Breathing in Lowlanders Older Than 40 Years at Altitude Effects of Melatonin on Sleep, Ventilatory Control and Cognition at Altitude. Effect of Acetazolamide on Lung Water Content by Ultrasound in Lowlanders Older Than 40 Years at Altitude Effect of Acetazolamide on Right Heart Function During Exercise in Lowlanders Older Than 40 Years at Altitude Effect of Acetazolamide on Visuo-motor Learning in Lowlanders Older Than 40 Years at Altitude Effect of Acetazolamide on Maximal Exercise Performance in Lowlanders Older Than 40 Years at Altitude Physiological Adaptations to Simulated Intermittent Altitude on Human Health and Performance Iron Status and Cardiopulmonary Physiology Effect of Acetazolamide on Right Heart Function at Rest in Lowlanders Older Than 40 Years at Altitude. Effect of Acetazolamide on Postural Control in Lowlanders Older Than 40 Years at Altitude Monitoring of the Cerebral Tissue Oxygenation and Perfusion in the Adapting Climber During Sleep in High Altitude The Psychophysiological Effect of Simulated and Terrestrial Altitude Relationship Between Succinate Dehydrogenase Mutations and High-Altitude Illness Cardio-respiratory Responses During Hypoxic Exercise in Individuals Born Prematurely Gut-microbiota Targeted Nutritional Intervention for Gut Barrier Integrity at High Altitude AZ, MZ, and the Pulmonary System Response to Hypoxia Study of the Effects of Iron Levels on the Lungs at High Altitude Effects of Aircraft Cabin Altitude on Passenger Comfort and Discomfort Three New Ideas to Protect Special Forces From the Stress of High Altitude Breathing Training to Improve Human Performance at High Altitude Oxidative Stress in Hypobaric Hypoxia Safety Evaluation of Aminophylline and Methazolamide Decompression Tables for Diving at Altitude Chronic Mountain Sickness, Systemic Vascular Function Evaluation of the Prevention and Treatment Effects of Chinese Medicine on High Altitude Illness Inhaled Budesonide for Altitude Illness Prevention Sickness Evaluation at Altitude With Acetazolamide at Relative Doses Prevention of Altitude Illness With Non-steroidal Anti-inflammatory Study (PAINS) Spectroscopic and Diffusion Weighted Analysis of the Effects of Dexamethasone on High Altitude Cerebral Oedema (HACE) Drug Combination on Exercise Performance at High Altitude Acclimatization Mechanisms During Ascent to 7500m Prevention of Acute Mountain Sickness by Intermittent Hypoxia Sickness Evaluation at Altitude With Acetazolamide at Relative Dosages Study Looking at End Expiratory Pressure for Altitude Illness Decrease (SLEEP-AID) Can Rhodiola Crenulata Intake Improve Oxygen Saturation and Decrease the Incidence of Acute Mountain Sickness Comparison of Metoclopramide and Ibuprofen for the Treatment of Acute Mountain Sickness A Trial of Acetazolamide Versus Placebo in Preventing Mountain Sickness During Rapid Ascent Training in Hypoxia to Prevent Acute Mountain Sickness Study of Compound Danshen Dripping Pills to Treat Acute Mountain Sickness Altitude Sickness Prevention With Ibuprofen Relative to Acetazolamide and Treatment Efficacy Controlled Hyperventilation as Prophylaxis for Acute Mountain Sickness Inhaled Budesonide and Acute Mountain Sickness Altitude Sickness Prevention and Efficacy of Comparative Treatments Alternative Treatments in Acute Mountain Sickness Effect of Acetazolamide on Acute Mountain Sickness in Lowlanders Older Than 40 Years Safety and Efficacy of T89 in Prevention and Treatment of Adults With Acute Mountain Sickness (AMS)

Brief Title

Study of Compound Danshen Dripping Pills to Treat Acute Mountain Sickness

Official Title

A Randomized, Double Blind, Placebo-controlled Study of Compound Danshen Dripping Pills in Preventing and Treating Acute Mountain Sickness

Brief Summary

      This study is to evaluate the efficacy and safety of compound danshen dripping pills in
      preventing and treating acute mountain sickness.
    

Detailed Description

      Compound danshen dripping pills is mainly used for the treatment and prevention of coronary
      heart disease and high-risk groups ,consists of Danshen (Radix Salviae Miltiorrhizae), Sanqi
      (Radix Notoginseng) and borneol.Danshen is the main drug efficacy of stasis, nourishing the
      nerves.Pharmacological studies have shown that Danshen can improve the oxygen carrying
      capacity of blood, increase oxygen supply to vital organs, effectively reduce hypoxia-induced
      heart and other vital organs, brain and kidney damage. Danshen can activate the fibrinolytic
      system, reduce blood viscosity, clear the microcirculation, promote blood circulation,
      increasing the amount of tissue oxygen by inhibiting platelet aggregation.This study is being
      conducted to evaluate the efficacy and safety of compound danshen dripping pills in
      preventing and treating acute mountain sickness, when compared with placebo.
    

Study Phase

Phase 1/Phase 2

Study Type

Interventional


Primary Outcome

The incidence of acute mountain sickness rapid radical to an altitude of 3000m above the plateau region compared to placebo


Condition

Acute Mountain Sickness

Intervention

Placebo

Study Arms / Comparison Groups

 Placebo Comparator
Description:  Placebo Comparator: controlled group Placebo,10pills,tid,po

Publications

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information


Recruitment Status

Drug

Estimated Enrollment

58

Start Date

June 24, 2016

Completion Date

July 13, 2017

Primary Completion Date

July 13, 2016

Eligibility Criteria

        Inclusion Criteria:

          -  aged 18-45 years,Male or female, plain natives

          -  first stationed at high altitude above 3,000 meters

          -  Upon physical examination before enrollment in good health

          -  BMI 19 to 24; (weight kg / height Sqm )

          -  voluntary signs the informed consent

        Exclusion Criteria:

          -  menstruation, pregnancy and breast-feeding women

          -  smoking, alcohol and drug abusers

          -  Clear history of drug allergy or allergic persons

          -  application of various drugs (including traditional Chinese medicine) two weeks ago

          -  Combined with severe liver and kidney dysfunction (cardiac function Grade ≥3, liver
             function Grade > 2 times of the upper limit of normal, Cr> upper limit of normal);

          -  Subject with blood donation experiences or blood test experiences within three months
             before be selected.

          -  C- reactive protein test results exceed the upper limit of normal.

          -  clinically significant gastrointestinal disease, mental illness and diabetes,
             hyperthyroidism and other metabolic diseases;

          -  Past suffering from cardiovascular and cerebrovascular disease

          -  fatigue syndrome that is not by high altitude-induced

          -  primary headache

          -  Vomiting due to other causes, such as digestive disorders as a result of the vomiting
             reflex, vomiting vestibular disorders, neurotic vomiting;

          -  Allergies

          -  Who participated in clinical trials of other drugs within a month

          -  blood circulation, increase immunity and antioxidant drug users
      

Gender

All

Ages

18 Years - 45 Years

Accepts Healthy Volunteers

Accepts Healthy Volunteers

Contacts

Min Zhao, PhD, , 

Location Countries

China

Location Countries

China

Administrative Informations


NCT ID

NCT03270787

Organization ID

TCM1421


Responsible Party

Sponsor

Study Sponsor

Tasly Pharmaceuticals, Inc.


Study Sponsor

Min Zhao, PhD, Study Director, Tasly Group, Co. Ltd.


Verification Date

August 2017